Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Innocan Pharma Corp C.INNO

Alternate Symbol(s):  INNPF

Healthcare
Innocan Pharma Corporation is an Israel-based pharmaceutical company active in the medical cannabis industry. It operates through three distinct operating segments: Research, Development, Marketing, Distribution and sales of InnoCan-branded over the counter (OTC) pharmaceutical products; Research and Development of Non-pharmaceutical products for third parties and Research and Development of... see more

Recent & Breaking News (CSE:INNO)

Leading American Dermatologist Dr. Mitchell Kline to Join Innocan Pharma's Scientific Advisory Committee

Newsfile March 23, 2021

Innocan Pharma Announces Proceeds of CDN $ 3.1M from the Exercise of Warrants Since January 1, 2021

Newsfile March 16, 2021

Innocan Pharma’s (CSE:INNO) patent application is pending for cannabis-based anti-itch treatment

Brieanna McCutcheon  March 10, 2021

Innocan Pharma Announces Patent Application for Novel Cannabis-Based Anti-Itch Treatment

Newsfile March 10, 2021

Innocan Pharma Announces the Completion of its First Full-Scale Manufacturing Run in the US and the Launching of its US Commercial Online Platform

Newsfile February 22, 2021

The StockTalk Cannabis Report: Jan 29, 2021

Dave Jackson January 29, 2021

Innocan Pharma Announces Proceeds of CDN $ 1.8M from the Exercise of Warrants Since December 1, 2020

Newsfile January 28, 2021

Innocan Pharma Produces CBD Loaded Liposomes

Brieanna McCutcheon  January 25, 2021

Innocan Pharma (CSE:INNO) produces CBD loaded liposomes

Brieanna McCutcheon  January 22, 2021

Innocan Pharma Announces Successful Production of CBD Loaded Liposomes under Aseptic Conditions

Newsfile January 22, 2021

Innocan Pharma Successfully Completes Large Scale Production of Exosomes

Newsfile January 14, 2021

Innocan Pharma Announces the Launch of Its Commercial Website

Newsfile January 5, 2021

Innocan Pharma Announces Closing of Private Placement

Newsfile December 31, 2020

Innocan Pharma Announces the Successful Completion of Its First Full-Scale Manufacturing Run in Europe and the Commencement of Its Full-Scale Manufacturing Run in the USA

Newsfile December 16, 2020

Innocan Pharma Completes Its Trademark Registration in the EU, UK and Switzerland

Newsfile December 10, 2020

Innocan Pharma to Participate in the Lytham Partners End of Year 1x1 Conference

Newsfile December 3, 2020

Innocan Reports Q3 2020 Financial Results

Newsfile December 2, 2020

Innocan Moves to an Advanced Efficacy Trial on Animals of Its Liposome-CBD Injection, Following Encouraging Results on the First Stage

Newsfile November 16, 2020

Innocan Enters Into Distribution Agreement to Sell its CBD Derma Cosmetic Products in Germany

Newsfile November 11, 2020

Innocan Pharma's Relief & Go CBD Spray Successfully Passes Safety Assessments and is Approved for Marketing in the European Union

Newsfile October 27, 2020